IRBESARTAN (Alembic Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the IRBESARTAN drug offered from Alembic Pharmaceuticals Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | IRBESARTAN |
| SUBSTANCE NAME: | IRBESARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-07-01 |
| END MARKETING DATE: | 0000-00-00 |
IRBESARTAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | IRBESARTAN from Alembic Pharmaceuticals Inc. |
| LABELER NAME: | Alembic Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/1) |
| START MARKETING DATE: | 2016-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62332-041_83f5d5c8-27c0-4208-a291-0c4aa55a1ff5 |
| PRODUCT NDC: | 62332-041 |
| APPLICATION NUMBER: | ANDA091236 |
Other IRBESARTAN Pharmaceutical Manufacturers / Labelers:
